- Home
- SAGE vs MERC Comparison
SAGE vs MERC Comparison
Compare SAGE & MERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- MERC
- Stock Information
- Founded
- SAGE 2010
- MERC 1968
- Country
- SAGE United States
- MERC Canada
- Employees
- SAGE N/A
- MERC N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- MERC Paper
- Sector
- SAGE Health Care
- MERC Basic Materials
- Exchange
- SAGE Nasdaq
- MERC Nasdaq
- Market Cap
- SAGE 444.1M
- MERC 432.3M
- IPO Year
- SAGE 2014
- MERC 1987
- Fundamental
- Price
- SAGE $7.31
- MERC $7.69
- Analyst Decision
- SAGE Hold
- MERC Hold
- Analyst Count
- SAGE 20
- MERC 2
- Target Price
- SAGE $10.67
- MERC $7.75
- AVG Volume (30 Days)
- SAGE 1.8M
- MERC 267.1K
- Earning Date
- SAGE 02-11-2025
- MERC 02-20-2025
- Dividend Yield
- SAGE N/A
- MERC 3.90%
- EPS Growth
- SAGE N/A
- MERC N/A
- EPS
- SAGE N/A
- MERC N/A
- Revenue
- SAGE $41,243,000.00
- MERC $2,043,360,000.00
- Revenue This Year
- SAGE $123.13
- MERC $5.02
- Revenue Next Year
- SAGE $69.65
- MERC $0.86
- P/E Ratio
- SAGE N/A
- MERC N/A
- Revenue Growth
- SAGE N/A
- MERC 2.48
- 52 Week Low
- SAGE $4.62
- MERC $5.33
- 52 Week High
- SAGE $23.22
- MERC $11.20
- Technical
- Relative Strength Index (RSI)
- SAGE 60.55
- MERC 72.63
- Support Level
- SAGE $7.00
- MERC $6.40
- Resistance Level
- SAGE $7.26
- MERC $6.73
- Average True Range (ATR)
- SAGE 0.19
- MERC 0.28
- MACD
- SAGE -0.06
- MERC 0.06
- Stochastic Oscillator
- SAGE 57.14
- MERC 70.85
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The solid wood segment consists of the manufacture, sale, and distribution of lumber, manufactured products wood pallets, electricity, biofuels, and wood residuals from sawmills and other facilities located in Germany and the United States. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.